Tech Company Financing Transactions

Zafgen Funding Round

Alta Partners, Brookside Capital and RA Capital participated in a $45 million Series E funding round for Zafgen. The funding round was announced on 12/4/2013.

Transaction Overview

Company Name
Announced On
12/4/2013
Transaction Type
Venture Equity
Amount
$45,000,000
Round
Series E
Proceeds Purpose
Proceeds from the financing will be used to support the continued development of beloranib, the Company's obesity therapeutic. Zafgen recently reported Phase 2 study results, which demonstrated that beloranib treatment led to significant weight loss and improvements in multiple cardiometabolic risk factors in 147 obese subjects.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
175 Portland St. 4th Floor
Boston, MA 02114
USA
Email Address
Overview
Zafgen (NASDAQ: ZFGN) is developing beloranib, a novel obesity therapy that demonstrates a unique mechanism of action, re-establishing balance to the ways the body produces and uses fat stored in adipose tissue.
Profile
Zafgen LinkedIn Company Profile
Social Media
Zafgen Company Twitter Account
Company News
Zafgen News
Facebook
Zafgen on Facebook
YouTube
Zafgen on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Jeffrey Hatfield
  Jeffrey Hatfield LinkedIn Profile  Jeffrey Hatfield Twitter Account  Jeffrey Hatfield News  Jeffrey Hatfield on Facebook
Chief Financial Officer
Patricia Allen
  Patricia Allen LinkedIn Profile  Patricia Allen Twitter Account  Patricia Allen News  Patricia Allen on Facebook
Chief Medical Officer
Dennis Kim
  Dennis Kim LinkedIn Profile  Dennis Kim Twitter Account  Dennis Kim News  Dennis Kim on Facebook
VP - Bus. Development
Brian McVeigh
  Brian McVeigh LinkedIn Profile  Brian McVeigh Twitter Account  Brian McVeigh News  Brian McVeigh on Facebook
VP - Bus. Development
James Vath
  James Vath LinkedIn Profile  James Vath Twitter Account  James Vath News  James Vath on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/4/2013: Exploros venture capital transaction
Next: 12/4/2013: GiveCorps venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to document every notable VC transaction. All VC database entries on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary